Nepsis Inc. Amgen Inc Transaction History
Nepsis Inc.
- $346 Million
- Q1 2025
A detailed history of Nepsis Inc. transactions in Amgen Inc stock. As of the latest transaction made, Nepsis Inc. holds 68,752 shares of AMGN stock, worth $19.1 Million. This represents 6.2% of its overall portfolio holdings.
Number of Shares
68,752
Previous 65,972
4.21%
Holding current value
$19.1 Million
Previous $17.2 Million
24.57%
% of portfolio
6.2%
Previous 2.55%
Shares
8 transactions
Others Institutions Holding AMGN
# of Institutions
3,309Shares Held
429MCall Options Held
8.06MPut Options Held
7.7M-
Vanguard Group Inc Valley Forge, PA52.9MShares$14.7 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.8 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.2MShares$8.12 Billion0.38% of portfolio
-
Capital World Investors Los Angeles, CA16.7MShares$4.65 Billion0.88% of portfolio
-
Morgan Stanley New York, NY16.2MShares$4.52 Billion0.37% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $149B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...